232 related articles for article (PubMed ID: 26584613)
1. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
2. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
4. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
[TBL] [Abstract][Full Text] [Related]
5. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
8. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
[TBL] [Abstract][Full Text] [Related]
10. Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.
Truchetet ME; Demoures B; Eduardo Guimaraes J; Bertrand A; Laurent P; Jolivel V; Douchet I; Jacquemin C; Khoryati L; Duffau P; Lazaro E; Richez C; Seneschal J; Doutre MS; Pellegrin JL; Constans J; Schaeverbeke T; Blanco P; Contin-Bordes C;
Arthritis Rheumatol; 2016 Nov; 68(11):2784-2794. PubMed ID: 27429171
[TBL] [Abstract][Full Text] [Related]
11. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.
Chiang TM; Takayama H; Postlethwaite AE
Thromb Res; 2006; 117(3):299-306. PubMed ID: 16378833
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.
Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.
Maugeri N; Rovere-Querini P; Baldini M; Baldissera E; Sabbadini MG; Bianchi ME; Manfredi AA
Antioxid Redox Signal; 2014 Mar; 20(7):1060-74. PubMed ID: 24070090
[TBL] [Abstract][Full Text] [Related]
16. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
17. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
[TBL] [Abstract][Full Text] [Related]
19. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
Yamaguchi Y; Okazaki Y; Seta N; Satoh T; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(6):R205. PubMed ID: 21050433
[TBL] [Abstract][Full Text] [Related]
20. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
Giusti B; Serratì S; Margheri F; Papucci L; Rossi L; Poggi F; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Matucci-Cerinic M; Abbate R; Fibbi G; Del Rosso M
Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
